Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Sep 30 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-30-2021-9

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 30, 2021, titled "Glenmark receives marketing approval for Ryaltris��, an innovative combination nasalspray, in 13 countries across the EU and UK".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases